Evidence map›Paper›PMID 27799486›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis

Amandeep Bajwa, Liping Huang, Elvira Kurmaeva, Hong Ye, Krishna R Dondeti, Piotr Chroscicki, Leah S Foley, Z Ayoade Balogun, Kyle J Alexander, Hojung Park and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Sphingolipid signaling in kidney diseases.American journal of physiology. Renal physiology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Bone marrow stromal cell antigen-1 deficiency protects from acute kidney injury.American journal of physiology. Renal physiology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury.American journal of physiology. Renal physiology · 2022
    Article
  17. Article
  18. Article
  19. Implications of Sphingolipid Metabolites in Kidney Diseases.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Amandeep BajwaDivision of Nephrology, ab9nh@virginia.edu dr5e@virginia.edu.
Liping HuangDivision of Nephrology.
Elvira KurmaevaDivision of Nephrology.
Hong YeDivision of Nephrology.
Krishna R DondetiDivision of Nephrology.
Piotr ChroscickiDivision of Nephrology.
Leah S FoleyDivision of Nephrology.
Z Ayoade BalogunDivision of Nephrology.
Kyle J AlexanderDivision of Nephrology.
Hojung ParkDivision of Nephrology.
Kevin R LynchDepartment of Pharmacology, University of Virginia, Charlottesville, Virginia.
Diane L RosinCenter for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and ab9nh@virginia.edu dr5e@virginia.edu.
Mark D OkusaDivision of Nephrology.
Immunité et Cancer · FRUniversity of Virginia · US

Funding

Sphingolipids in Acute Kidney Injury and Disease ProgressionR01DK085259 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2023
$5.0M
Leukocyte Trafficking in Acute Renal FailureR01DK062324 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OKUSA, MARK DOUGLAS · 2003 to 2016
$4.4M
Molecular Pharmacology of Sphingosine 1-PhosphateR01GM067958 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 2004 to 2014
$3.7M
Kidney Disease and InflammationT32DK072922 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2006 to 2020
$2.6M
Ultrasound for Non-Invasive Prevention of Acute Kidney InjuryR01DK105133 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2015 to 2019
$2.4M
MD-PHAR Controlling sphingosine 1-phosphate synthesis and traffickingR01GM121075 · NIGMS · UNIVERSITY OF VIRGINIA · PI LYNCH, KEVIN R., SANTOS, WEBSTER L · 2016 to 2020
$2.1M
In Vivo Probes of Sphingosine Kinase FunctionR01GM104366 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LYNCH, KEVIN R., SANTOS, WEBSTER L · 2013 to 2015
$1.1M
Sphingosine 1 phosphate receptors 1 and 3 as novel targets in transplantationK01DK091444 · NIDDK · UNIVERSITY OF VIRGINIA · PI BAJWA, AMANDEEP · 2012 to 2016
$579k
MBF Bioscience and Zeiss Microscope System for Stereology and Tissue MorphologyS10RR026799 · NCRR · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2010
$278k
Ischemic Reperfusion injury in Transplantation: Role of Sphingosine 1-phosphate receptors and dendritic cellsR03DK107941 · NIDDK · UNIVERSITY OF VIRGINIA · PI BAJWA, AMANDEEP · 2016 to 2017
$158k
NCRR NIH HHS S10 RR026799NIDDK NIH HHS K01 DK091444NIDDK NIH HHS R01 DK062324NIDDK NIH HHS R01 DK085259NIDDK NIH HHS R01 DK105133NIDDK NIH HHS R03 DK107941NIDDK NIH HHS T32 DK072922NIGMS NIH HHS R01 GM067958NIGMS NIH HHS R01 GM104366NIGMS NIH HHS R01 GM121075
6 · The paper itself

Abstract

Maladaptive repair after AKI may lead to progressive fibrosis and decline in kidney function. Sphingosine 1-phosphate has an important role in kidney injury and pleiotropic effects in fibrosis. We investigated the involvement of sphingosine kinase 1 and 2 (SphK1 and SphK2), which phosphorylate sphingosine to produce sphingosine 1-phosphate, in kidney fibrosis induced by folic acid (FA) or unilateral ischemia-reperfusion injury. Analysis of Masson trichrome staining and fibrotic marker protein and mRNA expression 14 days after AKI revealed that wild-type (WT) and

Indexed as

AnimalsFibrosisInterferon-gammaKidneyKidney DiseasesMicePhosphotransferases (Alcohol Group Acceptor)Sphingosine KinaseInterferon-gammaPhosphotransferases (Alcohol Group Acceptor)Sphingosine Kinasefolic acidischemia-reperfusionrenal fibrosissphingolipidT cells

Identifiers

PMID27799486
PMCPMC5373443
OpenAlexW2539691454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.